For decades, the European Union and China maintained an expansive and largely open scientific partnership, one built on the assumption that collaboration in research would foster mutual benefit and, perhaps, political goodwill. That era is now giving way to something far more guarded. Brussels is undertaking a sweeping reassessment of its research ties with Beijing, driven by mounting concerns over intellectual property theft, technology transfer to the Chinese military, and the broader geopolitical contest between Western democracies and authoritarian states.
The shift is neither sudden nor impulsive. It has been building for years, accelerated by the pandemic, Russia’s invasion of Ukraine, and growing evidence that China has systematically exploited open Western research frameworks for strategic advantage. What is emerging is a new European posture — one that seeks to preserve the benefits of international scientific exchange while imposing far stricter conditions on how, where, and with whom that exchange takes place.
From Open Arms to Open Eyes: The Policy Pivot Takes Shape
As reported by The Next Web, the European Commission has been actively recalibrating its approach to research partnerships with China, moving from a posture of broad engagement toward what officials describe as “strategic rebalancing.” The policy shift reflects a growing consensus among EU member states that scientific openness, long considered a pillar of European values, has been weaponized by actors who do not share those values.
The Commission’s approach draws on the broader “de-risking” framework that European Commission President Ursula von der Leyen articulated in 2023, which explicitly rejected full economic decoupling from China but called for reducing dependencies in critical sectors. Research and innovation are now firmly within that framework. The EU’s Horizon Europe program, the bloc’s €95.5 billion research and innovation initiative running from 2021 to 2027, has become a focal point. While Chinese entities are not formally banned from participating, the practical barriers to their involvement have been raised significantly, particularly in sensitive fields such as quantum computing, artificial intelligence, advanced materials, and space technology.
The Intelligence Dimension: Why Security Services Are Now at the Table
One of the most consequential changes in the EU’s approach is the growing involvement of national security and intelligence agencies in decisions that were previously left to scientists and research administrators. Multiple EU member states — including Germany, the Netherlands, and Sweden — have issued warnings about the risks of academic espionage linked to Chinese research partnerships. The Dutch intelligence service AIVD, for instance, has publicly stated that Chinese state-sponsored actors have targeted Dutch universities and research institutions to acquire sensitive knowledge and technology.
This securitization of research policy represents a fundamental change. Universities, which have historically prized autonomy and resisted government interference in their international partnerships, are being asked to conduct due diligence on foreign collaborators in ways that resemble corporate compliance programs. The European Commission has published guidelines urging research institutions to assess the risks of foreign interference, and several member states have gone further, establishing dedicated units to vet international academic partnerships. According to The Next Web, this marks a departure from the EU’s traditionally open approach to scientific cooperation and signals a new willingness to treat research policy as a component of national security strategy.
China’s Response: Frustration and Counter-Narratives
Beijing has pushed back against the EU’s tightening posture, framing it as ideologically motivated protectionism that undermines global scientific progress. Chinese officials and state media have repeatedly argued that scientific collaboration should remain free from geopolitical interference and that restricting partnerships will ultimately harm both sides. China’s Ministry of Science and Technology has emphasized the country’s commitment to international research cooperation, pointing to joint publications and shared breakthroughs as evidence of mutual benefit.
Yet the Chinese government’s own actions have complicated this narrative. Beijing’s 2023 revision of its counter-espionage law broadened the definition of espionage to include the transfer of data and information related to national security, creating a chilling effect on foreign researchers working in or with Chinese institutions. Several cases of foreign academics being detained or questioned in China have further eroded trust. European researchers report growing unease about conducting fieldwork in China or sharing preliminary findings with Chinese counterparts, fearing that information flows may be subject to state surveillance or appropriation.
The Numbers Behind the Partnership: Scale and Scope of EU-China Research Ties
The scale of EU-China scientific collaboration is enormous, and any recalibration carries significant practical consequences. China is the EU’s largest international co-publication partner outside of the United States and the United Kingdom. Thousands of Chinese researchers work at European universities and laboratories, and European institutions have benefited from Chinese funding, talent, and access to large-scale datasets and experimental facilities. In fields such as battery technology, renewable energy, and telecommunications, Chinese research output has been indispensable to European progress.
Disentangling these relationships is not straightforward. Many European research projects depend on Chinese partners for access to rare earth materials, manufacturing capacity, or patient populations for clinical trials. Cutting these ties abruptly would set back European research timelines and increase costs. The EU’s strategy, therefore, is not to sever connections but to impose conditions — requiring transparency about funding sources, restricting access to sensitive infrastructure, and demanding reciprocity in data sharing and intellectual property protections.
The Reciprocity Problem: Europe’s Core Grievance
At the heart of Europe’s frustration is a persistent asymmetry. European researchers operating in China face restrictions that have no equivalent in Europe. Access to Chinese data, laboratories, and academic institutions is often conditional on government approval and subject to opaque regulations. Meanwhile, Chinese researchers have enjoyed relatively unfettered access to European facilities, funding programs, and intellectual property. This imbalance has become politically untenable, particularly as EU member states face pressure from Washington to tighten technology controls and from their own publics to protect domestic innovation.
The European Commission has explicitly linked future research cooperation with China to progress on reciprocity. In practice, this means that Chinese participation in EU-funded research projects is increasingly contingent on Beijing’s willingness to open its own programs to European researchers on comparable terms. So far, progress on this front has been limited, and European officials privately acknowledge that China’s political system makes genuine reciprocity difficult to achieve.
Lessons From the Semiconductor Playbook
The EU’s approach to research partnerships with China mirrors, in many respects, the broader Western strategy on semiconductor export controls. Just as the United States, the Netherlands, and Japan have coordinated restrictions on the sale of advanced chipmaking equipment to China, European policymakers are now attempting to coordinate restrictions on the flow of sensitive knowledge. The goal is not to punish China but to ensure that European-funded research does not contribute to military capabilities or surveillance technologies that could be used against European interests.
This coordination is still a work in progress. EU member states have different levels of exposure to Chinese research partnerships and different appetites for confrontation. Germany, with its deep economic ties to China, has been more cautious than some smaller member states that see fewer downsides to a harder line. France has taken a middle path, investing heavily in its own research sovereignty while maintaining selective engagement with Chinese institutions in non-sensitive fields. The challenge for Brussels is to forge a coherent policy that accommodates these divergent interests without creating loopholes that undermine the overall strategy.
What Comes Next: The Institutional Machinery Grinds Forward
The EU’s recalibration of research ties with China is unlikely to produce a single dramatic policy announcement. Instead, it will manifest as a gradual tightening of rules, guidelines, and institutional practices. The European Research Council is expected to issue updated guidance on international partnerships. National funding agencies are revising their grant conditions to include security assessments. Universities are hiring compliance officers and establishing review boards to evaluate foreign collaborations.
The broader implications extend well beyond the laboratory. How Europe manages its research relationship with China will shape the future of global science, influence the trajectory of critical technologies, and test whether democratic societies can protect their strategic interests without sacrificing the openness that has made them innovative in the first place. As The Next Web noted, the EU’s approach represents a significant evolution in how the bloc thinks about the intersection of science, security, and foreign policy — a recalibration that, once set in motion, will be difficult to reverse.
For European researchers, the message is clear: the days of frictionless collaboration with Chinese partners are over. What replaces them will depend on whether Brussels can strike a balance between vigilance and vision — protecting what matters most without closing the door on partnerships that still have genuine value to offer.